Source: Journal of Psychopharmacology. Unidades: FM, IME
Subjects: ANOREXIA, COMORBIDADE, TRANSTORNO OBSESSIVO-COMPULSIVO, PSICOFARMACOLOGIA
ABNT
DINIZ, Juliana B. et al. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, n. 6, p. 603-611, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2014.02.011. Acesso em: 18 ago. 2024.APA
Diniz, J. B., Costa, D. L. C., Cassab, R. C. C., Pereira, C. A. B., Miguel, E. C., & Shavitt, R. G. (2014). The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, ( 6), 603-611. doi:10.1016/j.tiv.2014.02.011NLM
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.tiv.2014.02.011Vancouver
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.tiv.2014.02.011